SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
USA Rare Earth entered into Amendment No. 1 to its Merger Agreement with SVRE Holdings Ltd. on July 16, 2026, which modifies closing conditions by making an offtake agreement with a U.S. government-backed special purpose vehicle a condition precedent to completion. The underlying merger, originally dated April 19, 2026, involves USAR issuing 126.8 million shares and paying $300 million in cash consideration.
View raw filing on EDGAR →HEICO executed an Underwriting Agreement on July 13, 2026, and completed a public offering on July 16, 2026, of $550 million in 4.950% Senior Notes due 2031 and $650 million in 5.400% Senior Notes due 2036, totaling $1.2 billion in principal amount. The filing discloses the creation of direct financial obligations under Item 1.01 (Entry into Material Definitive Agreement) and Item 2.03 (Creation of Direct Financial Obligation), with the company intending to use net proceeds to pay down existing credit facility borrowings. This is a material debt issuance event.
View raw filing on EDGAR →The filing discloses completion of a material acquisition of Kira Pharmaceuticals by Jasper Therapeutics in an all-stock transaction, combined with a concurrent $132 million private placement financing. The press release explicitly states "Jasper has completed the acquisition of Kira Pharmaceuticals" and describes a consolidated pipeline, management structure, and significant ownership dilution (Jasper pre-acquisition shareholders will own ~6.68% post-transaction). This is a transformative M&A event material to investors.
View raw filing on EDGAR →Mercator Acquisition Corp. consummated its IPO on July 10, 2026, raising $172.5 million in gross proceeds through issuance of 17.25 million units and entering into multiple material definitive agreements (underwriting, warrant, trust, registration rights, and warrant purchase agreements) that constitute the IPO structure.
View raw filing on EDGAR →Mercator Acquisition Corp. completed a private placement of 4,500,000 warrants to the Sponsor and Underwriter at $1.00 per warrant, generating $4.5 million in gross proceeds pursuant to Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →This press release announces a clinical development milestone: the first patient dosed in the intermittent weekly dosing arm of a Phase 1 trial for AN9025, a pan-RAS(ON) inhibitor. While the company is clinical-stage and this represents progress in its lead therapeutic candidate, the disclosure is a clinical milestone rather than a discrete material event (M&A, restatement, executive change, etc.). The announcement is material to investors assessing the company's pipeline advancement and clinical strategy, but does not fit the specific event-type taxonomy; it is an operational/strategic milestone in drug development.
View raw filing on EDGAR →Freedom Metals Acquisition Corp. consummated its IPO on July 9, 2026, raising $275 million in gross proceeds from the sale of 27.5 million units at $10.00 per unit, plus a concurrent private placement of 825,000 units for $8.25 million. While technically an IPO rather than a traditional M&A transaction, SPAC IPOs are classified as ma_activity because they represent the formation of a blank-check acquisition vehicle with the explicit purpose of effecting a business combination—a material capital-raising event that establishes the vehicle for future M&A. The disclosure emphasizes the Company's intent to pursue a Business Combination in the mining and critical minerals industry, with $275 million placed in trust for that purpose.
View raw filing on EDGAR →Jasper Therapeutics completed the acquisition of Kira Pharmaceuticals on July 16, 2026, in an all-stock merger transaction involving issuance of 5.2 million shares of common stock and 4.6 million shares of convertible preferred stock to Kira shareholders. The transaction fundamentally changes the ownership and control structure of the registrant, with Kira shareholders owning approximately 49.86% of the post-transaction equity on a fully diluted basis.
View raw filing on EDGAR →Concurrent with the Kira Pharmaceuticals acquisition, Jasper Therapeutics completed a $132 million PIPE offering of approximately 4.7 million shares of unregistered preferred stock to accredited investors under Section 4(a)(2) and Regulation D. PIPE investors are expected to own approximately 43.46% of the combined company on a fully diluted basis.
View raw filing on EDGAR →Effective immediately after the merger closing, Patrick Crutcher was appointed as a Class I director and Matthew Ros was appointed as Chief Operating Officer of the combined company. These appointments represent material forward-looking leadership changes tied to the merger transaction.
View raw filing on EDGAR →In connection with the merger and $132 million PIPE financing, Jasper Therapeutics filed a Certificate of Designation for Non-Voting Convertible Preferred Stock establishing the terms, preferences, voting restrictions, conversion ratio (61:1), dividend rights, and protective provisions for preferred holders. These structural provisions are material to the post-transaction capital structure.
View raw filing on EDGAR →The disclosure announces publication of a coordinated federal and state permitting schedule for the Arctic Project, establishing a defined timeline toward a Record of Decision by September 2028. This is a material operational and regulatory milestone for a mining development company—it converts permitting from an open-ended risk into a publicly tracked sequence of milestones and materially advances the project toward a construction decision. While not a specific named event type, this is clearly an operational/strategic business milestone that would affect a reasonable investor's assessment of project execution risk and timeline certainty.
View raw filing on EDGAR →This exhibit is a news release disclosing results of an updated Preliminary Economic Assessment (PEA) for the Carangas mining project in Bolivia. The PEA shows post-tax NPV of $2.65 billion and IRR of 35.9%, with detailed production and cost projections. While the document contains financial projections and economic analysis, it is fundamentally a technical/operational disclosure about project advancement and feasibility—not a discrete financial event like earnings, debt issuance, or M&A. The company is advancing technical work, permitting, and planning a 30,000-meter drilling campaign. This is material to investors as it demonstrates project viability and development progress, but it is operational/strategic in nature rather than fitting a specific financial or governance category.
View raw filing on EDGAR →Cohen & Steers disclosed its quarterly financial results for Q2 2026 (quarter ended June 30, 2026) via Item 2.02, with the full earnings release attached as Exhibit 99.2. The disclosure includes diluted EPS of $0.95 ($0.85 adjusted), AUM of $100.1 billion, net inflows of $1.3 billion, and detailed operating and financial highlights. This is a standard quarterly earnings announcement material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →The filing discloses operational performance metrics for Copel's distribution business in 2Q26, reporting a 7.2% increase in billed grid market and 7.3% growth in electricity consumption. While this is substantive operational data affecting investor assessment of the company's business performance and market position, it does not constitute a formal earnings release (which would present comprehensive financial results) nor a periodic financial report. It is a discrete operational announcement of material business metrics.
View raw filing on EDGAR →Ecopetrol Investimentos received a favorable CVM (Brazilian Securities and Exchange Commission) ruling on an administrative appeal related to a public tender offer for acquisition of shares (OPAV). The CVM lifted a previously imposed suspension and granted until July 22, 2026 to amend and publish the offer document. This constitutes material M&A activity—a tender offer acquisition proceeding through a regulatory milestone that removes a material impediment to completion.
View raw filing on EDGAR →The Board of Directors meeting minutes disclose the resignation of Mr. Nitin Prabhu from his role as Member of the Board of Directors, effective July 28, 2026. This is a departure of a director, which is a material governance event that would affect a reasonable investor's assessment of the company's leadership composition and continuity.
View raw filing on EDGAR →The 6-K body discloses a Board of Directors declaration of Interest on Capital (IoC) in the gross amount of R$500,000,000.00 (approximately $412.5 million net after 17.5% withholding tax), approved on July 16, 2026, with a per-share amount of R$0.15646482856 gross. This is a distribution to shareholders pursuant to the Company's Bylaws and Brazilian tax law, and constitutes a material return of capital that would affect investor assessment of the registrant's capital allocation and shareholder returns.
View raw filing on EDGAR →This is a call notice and manual for an Extraordinary General Meeting scheduled for August 18, 2026, inviting shareholders to vote on fixing the board size at 13 members, electing two new directors (Daniel Barriuso Rojo and Gilson Finkelsztain), and confirming the board composition. However, the meeting has not yet occurred as of the filing date (July 16, 2026), so this is a prospective notice rather than a disclosure of actual vote results. The taxonomy's `shareholder_vote_results` type is defined as "Results of a vote at an annual or special meeting," which typically applies post-meeting. This document is pre-meeting guidance, making it more aligned with governance-related shareholder communication, but the closest available category is `shareholder_vote_results` given the focus on board elections and shareholder voting procedures.
View raw filing on EDGAR →The Board of Directors approved a declaration of interest on capital (IoC) in the gross amount of R$500,000,000.00 (R$0.156464828562 per share), to be credited to shareholders based on shareholding position as of July 27, 2026, with payment by April 30, 2027. This is a material distribution of capital to shareholders, meeting the definition of dividend_distribution.
View raw filing on EDGAR →The 6-K furnishes minutes of Telefônica Brasil's Fiscal Council meeting held July 14, 2026, in which the Council unanimously approved a proposal to declare an Interest on Capital (IoC) distribution of R$500,000,000 gross (R$412,500,000 net) to shareholders, equivalent to R$0.156464828562 per share gross. The distribution will be credited based on shareholding position as of July 27, 2026, with payment by April 30, 2027. This is a material capital distribution to shareholders.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of San Francisco. Schedule A details three specific debt issuances on trade dates 7/13/2026 and 7/14/2026, totaling approximately $520 million in principal ($10M + $10M + $500M), with maturity dates ranging from 2027 to 2031. This is a classic Item 2.03 debt issuance disclosure.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A lists specific debt securities issued on trade dates in July 2026, including fixed-rate bonds ranging from 2-year to 15-year maturities with principal amounts totaling approximately $1.075 billion. This is a classic debt issuance disclosure under Item 2.03, and the Bank explicitly notes that "consolidated obligations issuance is material to the Bank."
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details four specific debt issuances with trade dates of 07/13/2026, totaling approximately $465 million in principal across fixed-rate bonds (maturing 2029, 2031, 2046) and a variable-rate floater (maturing 2026). This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →The filing discloses the issuance of a Consolidated Bond with a principal amount of $20,000,000, trade date 7/13/2026, maturing 7/28/2031, with a 5.000% fixed coupon. This is a direct creation of a financial obligation under Item 2.03, representing a new debt issuance by the Federal Home Loan Bank of Cincinnati. The disclosure explicitly states that Consolidated Obligations are the primary funding mechanism for the FHLB and are joint and several obligations of the 11 Federal Home Loan Banks.
View raw filing on EDGAR →The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Chicago. Schedule A details nine separate debt issuances with trade dates of 7/13/2026 and 7/14/2026, totaling approximately $4.435 billion in principal amount, with maturities ranging from October 2026 to July 2031. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Boston. Schedule A details three specific debt issuances with trade dates in July 2026, including a $10 million fixed-rate bond due 2031, a $250 million variable-rate discount note due 2026, and a $10 million fixed-rate bond due 2029. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →The filing discloses the issuance of consolidated obligations (debt securities) by the Federal Home Loan Bank of Atlanta. Schedule A reports two specific debt issuances: a $1 billion variable-rate bond maturing 11/16/2026 (trade date 7/13/2026) and a $10 million fixed-rate callable bond maturing 10/27/2027 (trade date 7/13/2026). These represent the creation of direct financial obligations under Item 2.03, which is the standard 8-K item for debt issuance disclosures.
View raw filing on EDGAR →The Federal Home Loan Bank of Indianapolis discloses its assumption of primary obligor status on consolidated obligation bonds totaling approximately $415 million in par value across three separate issuances with maturities ranging from 2028 to 2031. This constitutes creation of direct financial obligations under Item 2.03, meeting the definition of debt issuance. The disclosure includes specific trade dates, settlement dates, maturity dates, coupon rates, and par amounts for each bond tranche, confirming the creation of new debt obligations.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Dallas. Schedule A reports two bond issuances: a $10 million fixed-rate bond maturing in 2031 and a $1.5 billion variable-rate floater maturing in 2026, both committed on trade dates in July 2026. This represents a material debt issuance event under Item 2.03, creating new direct financial obligations totaling approximately $1.51 billion.
View raw filing on EDGAR →The filing discloses the dismissal of Grant Thornton LLP as CODI's independent registered public accounting firm effective July 16, 2026, and the simultaneous appointment of Deloitte & Touche LLP as the new auditor. This is a classic auditor change under Item 4.01. The materiality is heightened by the fact that Grant Thornton's prior reports contained going-concern warnings and references to restatements, and expressed adverse opinions on internal controls due to material weaknesses—factors that would affect investor assessment of the company's financial reliability and governance.
View raw filing on EDGAR →Etsy disclosed entry into a Second Amendment to a material definitive agreement for the sale of its wholly-owned subsidiary Depop to eBay. The filing explicitly states this is an "Entry into a Material Definitive Agreement" under Item 1.01, and the transaction involves a disposition of a significant subsidiary with regulatory clearance from the CMA and an expected closing date of July 30, 2026. This is a material acquisition/disposition event requiring 8-K disclosure.
View raw filing on EDGAR →Main Street Capital issued a press release on July 16, 2026 announcing preliminary estimates of its financial condition and results of operations for the fiscal quarter ended June 30, 2026, including net investment income per share ($0.95–$0.99), distributable net investment income per share ($1.02–$1.06), net asset value per share ($33.88–$33.96), and an estimated annualized return on equity of over 18%. This is a classic earnings release disclosure under Item 2.02, material to investors assessing the registrant's quarterly financial performance.
View raw filing on EDGAR →The disclosure reports the Pennsylvania Public Utility Commission's approval of a rate adjustment for Pennsylvania American Water (a subsidiary), authorizing an annual revenue increase of approximately $74.9 million to support infrastructure improvements. This is a material regulatory decision affecting the company's operations and financial performance, but does not fit neatly into specific financial categories (not a debt issuance, dividend, or impairment) or governance categories. It is a significant operational/regulatory milestone that warrants classification as operational_other.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q3 fiscal 2026 (ended June 27, 2026) disclosing net earnings of $9.0 million ($0.46 per share), net sales of $197.7 million, and gross profit of $20.1 million. The news release is furnished as Exhibit 99.1 and includes consolidated financial statements (income statement, balance sheet, and cash flow statement), which is the typical format for an Item 2.02 earnings disclosure. Material to investors as it reports quarterly financial performance.
View raw filing on EDGAR →The Board of Directors declared a quarterly cash dividend of $0.33 per common share payable on August 17, 2026. This is a routine but material capital allocation decision that affects shareholders and is customarily disclosed in 8-K filings under Item 8.01 (Other Events). Dividend declarations are material to investors assessing the registrant's capital management and shareholder returns.
View raw filing on EDGAR →TMTG announced the launch of Truth API, a new business-to-business data-licensing service designed to monetize proprietary assets through a "high-margin, recurring revenue stream." This is a material operational and strategic business development—the introduction of a new product line and revenue model—but does not fit neatly into any specific event category (not earnings, M&A, litigation, etc.). The disclosure emphasizes that customers have already signed up and the service launches August 1, 2026, making it a concrete operational milestone rather than a routine announcement.
View raw filing on EDGAR →LGL Group announced preliminary results of a transferable subscription rights offering that generated approximately $41.7 million in gross proceeds through the issuance of 6,042,031 shares of common stock at $6.90 per share. This is a material dilutive equity issuance that increases the company's capital base and shareholder count, affecting existing shareholders' ownership percentages and earnings per share.
View raw filing on EDGAR →QumulusAI, Inc. shareholders approved and adopted the 2026 Equity Incentive Plan, which permits grants of stock options, restricted stock units, performance awards, and other equity-based compensation to employees, directors, and consultants, with an initial share pool of 4,770,000 shares and annual increases.
View raw filing on EDGAR →QumulusAI, Inc. disclosed a material modification to the rights of security holders, incorporating Item 5.03 by reference; the specific nature of the modification cannot be determined from the cross-reference alone but relates to governance matters.
View raw filing on EDGAR →Rent the Runway held its Annual Meeting of Stockholders on July 14, 2026, with shareholders voting on 12 items including election of two Class II directors (Teri Bariquit and Daniel Rosensweig), ratification of PricewaterhouseCoopers LLP as auditor, approval of amendments to the Certificate of Incorporation, and approval of an increase to the 2021 Incentive Plan. All items passed with detailed vote tallies reported.
View raw filing on EDGAR →Suchi Sastri was appointed as a Class III director effective July 14, 2026, and concurrently appointed to the Audit Committee, restoring the company's compliance with Nasdaq listing rules requiring three independent Audit Committee members.
View raw filing on EDGAR →Cosmos Health held its 2026 Annual Meeting of Stockholders on July 15, 2026, where shareholders voted on four proposals: election of six directors, ratification of the independent auditor, approval of the 2026 Equity Omnibus Plan, and approval of Series B Preferred Stock designation and issuance. All four proposals passed with affirmative vote percentages ranging from 78.98% to 84.24%.
View raw filing on EDGAR →The company implemented material modifications to the rights of security holders through amendments to its articles of incorporation, as disclosed under Item 3.03 with substance incorporated by reference from Item 5.03. The specific nature of these modifications relates to governance-level changes affecting shareholder rights and protections.
View raw filing on EDGAR →The filing discloses the appointment of Ryan Carver as Chief Development Officer of Soluna Holdings, effective immediately on July 16, 2026. Carver is a senior executive from Microsoft with extensive experience leading hyperscale AI data center construction programs, and will report directly to the CEO and sit on the Senior Leadership Team. This is a material executive appointment to a key operational leadership role.
View raw filing on EDGAR →Galmed announces a breakthrough development of a novel lipid nanoparticle (LNP) formulation of Aramchol in collaboration with Barcode Nanotech, targeting cardiac delivery. This is a material operational/strategic milestone—a significant advancement in the company's product pipeline and formulation technology that could open new therapeutic indications (cardiac fibrosis) and partnerships. While not a discrete M&A transaction, earnings release, or executive change, it represents a material development in the company's core drug-development strategy and competitive positioning in cardiometabolic diseases.
View raw filing on EDGAR →NextBoat issued a press release on July 16, 2026 disclosing "Record Second Quarter Performance" and guidance updates, filed under Item 7.01 (Regulation FD Disclosure) with the press release attached as Exhibit 99.1. The disclosure highlights record transaction closings, record quarterly sales, 120% year-over-year transaction volume growth, and expectations of reaching or near profitability for Q2 2026. While technically a business update rather than audited financial results, the substance is an earnings-related disclosure of quarterly performance metrics and forward guidance that would materially affect investor assessment of the company's financial trajectory.
View raw filing on EDGAR →The filing discloses a 1-for-10 reverse stock split of CDT Equity Inc.'s common stock, approved by the board and previously authorized by stockholders. The reverse split becomes effective July 17, 2026, and is undertaken "to ensure continued compliance with the Nasdaq bid-price rule." This is a governance and capital structure event—an amendment to the Certificate of Incorporation (Item 5.03)—that materially affects the rights and economic interests of security holders by consolidating shares and adjusting exercise prices of equity awards and warrants.
View raw filing on EDGAR →SharonAI announced a US$1.32 billion five-year cloud computing infrastructure agreement with a global AI Lab, with revenue expected to commence in Q1-Q2 2027. This represents a material strategic contract and operational milestone for the company's AI Factory deployment in New Zealand. While the filing is structured as a Regulation FD disclosure (Item 7.01) via press release, the substance is a significant commercial contract that does not fit the specific categories of M&A, debt issuance, or other named financial events, making it an operational business event.
View raw filing on EDGAR →CBL International announced a 1-for-13 reverse share split "primarily to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) relating to the maintenance of the minimum bid price per share." This disclosure reveals the company has fallen below Nasdaq's minimum bid price requirement and faces delisting risk absent this remedial action. The reverse split is a direct response to a continued listing rule violation, making this a material delisting-risk disclosure.
View raw filing on EDGAR →